Hesperos
Biotechnology, 3259 Progress Dr, Orlando, Florida, 32826, United States, 11-50 Employees
Phone Number: 40********
Who is HESPEROS
Hesperos, Inc. is accelerating drug discovery by providing safety and efficacy testing of chemicals and novel therapeutics for the pharmaceutical, cosmetic, and food industries using its ...
Read More
- Headquarters: 3259 Progress Dr, Orlando, Florida, 32826, United States
- Date Founded: 2015
- Employees: 11-50
- Revenue: $5 Million to $10 Million
- Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8731
Hesperos Org Chart and Mapping
Similar Companies to Hesperos
Numa Biosciences
- 11-50
- $ 10 Million to 25 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Hesperos
Answer: Hesperos's headquarters are located at 3259 Progress Dr, Orlando, Florida, 32826, United States
Answer: Hesperos's phone number is 40********
Answer: Hesperos's official website is https://hesperosinc.com
Answer: Hesperos's revenue is $5 Million to $10 Million
Answer: Hesperos's SIC: 8731
Answer: Hesperos has 11-50 employees
Answer: Hesperos is in Biotechnology
Answer: Hesperos top competitors include: Numa Biosciences
Answer: Hesperos contact info: Phone number: 40******** Website: https://hesperosinc.com
Answer: Hesperos, Inc. is accelerating drug discovery by providing safety and efficacy testing of chemicals and novel therapeutics for the pharmaceutical, cosmetic, and food industries using its patented, Human-on-a-Chip platform. Bringing together biologists, surface chemists, and engineers, our team is producing some of the world's most advanced organs-on-a-chip platforms. From gene expression to electrophysiology, we recreate key components of organs in an interconnected, functional system. Chemically patterned microchips enable real-time, non-invasive monitoring of organ function where we use sophisticated measurement techniques to detect minute changes. This breakthrough technology enables unprecedented visibility into specific disease states and how the human body will respond to treatment - something that previously required costly animal testing and human trials to determine. The functional, interconnected, human in vitro platform, provides preclinical insight into the efficacy and toxicity of novel therapeutics. Ultimately, Hesperos Human-on-a-Chip is reducing the need for animal testing in drug discovery while enabling research into rare diseases previously considered untreatable.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month